• +39 06 916391
  • Lun - Ven: 8:00 - 17:00
  

Italy is in pole position, with 73% of European production. Lazio, together with Lombardy, are the leading Italian regions

ITC-Farma-newsROME - Nutraceuticals are a fairly new pharmaceutical category. The term was coined in 1989 by the American medical researcher Stephen De Felice to define a discipline which combines the study of nutrition with the sector of pharmaceutics. More commonly known as dietary supplements or food additives, their rate of production has undergone a phenomenal growth and it now amounts to a turnover of 3.3 billion euros in Italy alone. Lazio and Lombardy are the national leaders in this strategic sector, in terms of both production and consumption. The survey “The Italian food supplement supply chain”, which was recently presented to the Italian Chamber of Deputies, reveals the existence of a market that has gained the trust not only of consumers, but also of many doctors, who are increasingly prescribing the use of these products. The genuine area of excellence in this “Made in Italy” sector is represented by the practice of contract manufacturing by third parties. This industrial model has been adopted by several leading multinationals, which see Italy as one of the most competent sources of products in the world, and this confirms the high quality of production processes in this country. Thanks to the new technologies that are now available to the firm, as well as its innovative research and development laboratory, ITC Farma has been able to set up some strategic collaborations with university research teams, and it can nowsatisfy most requests for the pharmaceutical market, including the development of new product formulations in the field of nutraceuticals. As Dr. Guglielmo Frontini, the plant director of ITC Farma, explains: “thanks to our decades of experience, in addition to the new structures with which we are now equipped, our company is able to open up to new markets, and we can beperfectly integrated with every demand. In addition to the prevalent production of pharmaceuticals, food and nutrients represent a very important segment, in terms of development as well as quality. Today in the food sector we are able tomanage 800 kilograms of powders each working day, which are treated to produce granules for sachets or for compression. In this way we can make and package any kind of product required.” Frontini concludes by pointing out that “today, by means of the dynamics of major industrial investments, we are also ready for the challenge represented by the sector of nutraceuticals: a market that is becoming ever more important andpresent in our daily lives.”

The pharmaceutical company of Pomezia is now equipped with a modern avant-garde laboratory 


ITC Farma punta alla massima innovazione dei processi produttiviROME – Technological innovation, academic research and entrepreneurial capacities that continually surpass all expectations. These are the factors that constitute the strength of ITC Farma, which has recently been equipped with a state-of-the-art laboratory and new technological instruments.
 This exciting new development is only the latest improvement to be introduced by ITC Farma, and it has allowed the firm to renew its production modalities, while acquiring a pharmaceutical research laboratory that uses high level equipment and scientific technologies that are truly unique, with a degree of reliability and performance that isperfectly appropriate for a strategic sector such as that of pharmaceutics.

 Ongoing research, development and constant quality monitoring will also play a decisive role in this context, thanks to an active collaboration between leading experts in the sector from the Faculty of Pharmacy and Medicine of the “Sapienza” University of Rome: Professor Silvio Massimo Lavagna and Professor Daniela Secci,and thepharmaceutical staff of ITC Farma, supervised by the director of the plant Dr. Guglielmo Frontini and Dr. Stefano Di Manno, the head of quality-control.

 These new-generation technologies will therefore make it possible to further enhance the existing production cycles, as well as to diversify into several new areas, optimizing research processes with constant attention towards quality, safety and environmental sustainability. This is a genuine qualitative leap forward with a wider international resonance, which will certainly constitute an important stimulus for pharmaceutical production in the Lazio region of central Italy.

The excellent results of synergy between industry and academic research

ITC-Farma-e-Universita-Sapienza--un-impulso-di-crescita-e-competitivita-per-il-PaesePOMEZIA – The synergy between the worlds of academic research and industry can produce positive effects for the development of the country, as regards skills as well as economic development. One example of this is the scientific and technological collaboration recently established between the Department of Chemistry and Pharmaceutical Technology of the Sapienza University and the company ITC Farma. These two important entities have decided to join forces and to participate in the call for proposals of the Lazio region Life 2020, in order to enhance and increase their knowledge and skills, so as to reach their strategic goals for growth and innovation, as well as for competitive positioning on the international market. “The objectives that we have achieved – explains Professor Silvio Lavagna – have exceeded our expectations. This important result has been attained also thanks to the collaboration of Professor Bruno Botta, the director of the Chemistry and Pharmaceutical Technology Department of the Sapienza University, together with Professor Alberto Boffi and Professor Daniela Secci. It provides further confirmation of the fact that we are going in the right direction”.

“The new technologies with which we are equipped - points out Dr. Guglielmo Frontini, the plant director of ITC Farma – have raised our capacity to a qualitative and innovative level that is present only in the largest pharmaceutical companies. Furthermore the creation of the research department will allow ITC to optimize existing processes, and to speed up the activities of process and method transfer that are very important for companies, like ours, the core business of which is represented by contract manufacturing and the development of new pharmaceutical products.”

Guarda il video